Please sign in to follow a disease.
Anna Stanhewicz, Phd
Clinical trials sponsored by Anna Stanhewicz, Phd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a pregnancy complication leave lasting damage to blood vessels? new study investigates Results expected Sep 2026 (estimated)
- Vaping's hidden danger: study reveals Sex-Based differences in blood vessel damage Results expected Dec 2026 (estimated)
- Could oxidative stress be the hidden culprit behind blood vessel damage after gestational diabetes? Results expected Dec 2026 (estimated)
- Can a drug improve blood vessel health in women after preeclampsia? Results expected Jan 2027 (estimated)
- Depression drug may mend blood vessels damaged by preeclampsia Results expected Mar 2027 (estimated)
-
Blood vessel damage after gestational diabetes: is a rogue enzyme to blame?
Knowledge-focused OngoingThis early-phase trial tests whether an enzyme called NADPH oxidase contributes to blood vessel problems in otherwise healthy women who had gestational diabetes. Researchers will measure how small blood vessels in the skin respond to substances that normally widen them, with and …
Early phase 1 • Sponsor: Anna Stanhewicz, PhD • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
Can a drug fix blood vessels after preeclampsia? early study hints at possibility
Knowledge-focused OngoingThis study looks at why women who had preeclampsia may have lasting blood vessel problems and inflammation. Researchers will test a drug called eplerenone on a small patch of skin to see if it improves blood vessel function. The study involves 40 women, some with a history of pre…
Early phase 1 • Sponsor: Anna Stanhewicz, PhD • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC